Publications
The publications search is performed on the
National Library of Medicine's PubMed database. The search may be slow during
high traffic hours, may return articles authored by another researcher with a similar
name and may not always find all of a researcher's articles.
Patents
- M. K. Safo, R. Danso-Danquah, S. S. Nokuri, F. N. Musayev, G. S. Joshi, J. C. Burnett, and D. J. Abraham. Antisickling Agents. US Patent No. 7160910, 2007.
- M. K. Safo, R. Danso-Danquah, G. S. Joshi, and D. J. Abraham. Antisickling Agents. US Patent No. 7,119,208 B2, 2006.
- D. J. Abraham, G. S. Joshi, S. J. Hoffman, M. Grella, R. Danso-Danquah, A. Yousseff, M. K. Safo, S. Kulkarni. "Substituted Chiral Allosteric Hemoglobin Modifiers". US Patent No. 6,486,342 B1, 2002.
- D. J. Abraham, M. K. Safo, T. Boyiri, and R. E. Danso-Danquah. "Aldehydic Agents for Allosteric Modification of Hemoglobin". US Patent No. 5,599,974, 1997.
Recent Publications
- 1.F. N. Musayev, M. Di Salvo, M. Saveedra, R. Contestabile, M. S. Ghatge, V. Schirch, M. K. Safo. “Crystal structure of human pyridoxine 5'-phosphate oxidase mutant R229W: Structural basis for reduced PNP Oxidase catalytic activity in neonatal epileptic encephalopathy disorder” J. Biol. Chem. 2009.
- 2.A.K. Gandhi, M.S. Ghatge, F.N. Musayev, A. Sease, S.O.Aboagye, M.L. di Salvo, V. Schirch, and M. K. Safo. “Kinetic and structural studies of the role of the active site residue Asp235 of human pyridoxal kinase”. Biochem. Biophys. Res. Commun., 2009.
- 3.J. D. Jenkins, F.N. Musayev, R. Danso-Danquah, D.J. Abraham, M. K. Safo. “Structure of relaxed-state human hemoglobin: insight into ligand uptake, transport and release.” Acta Crystallogr D. 2009, 65: 41-48.
- 4.I. N. Nnamani, G. S. Joshi, R. Danso-Danquah, O. Abdulmalik, T. Asakura, D. J. Abraham, and M. K. Safo. “Pyridyl Derivatives of Benzaldehyde as Potential Antisickling Agents.”Chemistry & Biodiversity, 2008 5:1762-1769.
- 5.J. Yi, M. K. Safo, and G. B. Richter-Addo. “The Nitrite Anion Binds to Human Hemoglobin via the Uncommon O-Nitrito Mode.” Biochemistry, 2008, 47: 8247-8249.
- 6. F. N. Musayev, M. L. di Salvo, T.-P. Ko, A. K. Gandhi, A. Goswami, V. Schirch, and M. K. Safo. “Crystal Structure of human pyridoxal kinase: Structural basis of M+ and M2+ activation.” Protein Sci., 2007, 16: 2184-2194.
- 7. M. K. Safo, F. N. Musayev, M. di Salvo, S. Hunt, and V. Schirch. “Crystal Structure of Pyridoxal Kinase from the Escherichia coli PdxK gene: Implications for the Classification of Pyridoxal Kinases.” J. Bacteriol. 2006, 4542-4552.
- 8. M. K. Safo and D. J. Abraham. “The Enigma of the Liganded Hemoglobin End-State: A Novel Quaternary Structure of Human Carbonmonoxy Hemoglobin.” Biochemistry, 2005, 44, 8347-8359.
- 9. O. Abdulmalik, M. K. Safo, N.B. Lerner, J. Ochotorena, E. Daikhin, V. Lakka, R. Santacroce, D. J. Abraham and T. Asakura. “5-hydroxymethyl-2-furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells.” Br. J. Hematol. 2005,128, 552-561